Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-10

Clinical Trial Update: Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hypertonic saline in combination with terlipressin for septic shock/sepsis-associated hypotension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic Saline (Hypertonic saline)
  • Terlipressin (terlipressin)

Snippet

Sponsor: Hospital General de Ciudad Real | Conditions: Septic Shock, Sepsis-associated Hypotension | Phase 3 | Status: TERMINATED